{
  "id": "5e764732c6a8763d23000017",
  "type": "yesno",
  "question": "Can AGY be used as antidiuretic replacement therapy?",
  "ideal_answer": "No, AGY is an oral egg yolk anti-gliadin antibody used to neutralize gluten. It is used in patients with celiac disease.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28035551"
  ],
  "snippets": [
    {
      "text": "AGY, a Novel Egg Yolk-Derived Anti-gliadin Antibody, Is Safe for Patients with Celiac Disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28035551",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Oral egg yolk anti-gliadin antibody (AGY) is a novel treatment to neutralize gluten and may improve the efficacy of the GFD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28035551",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "To determine the safety, tolerability, and potential efficacy of AGY in patients with CD.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28035551",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Most patients had fewer celiac symptoms (especially tiredness, headache, and bloating), improved quality of life, lowered antibodies, and lowered LMER when taking AGY compared to the run-in period.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28035551",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In our cohort, AGY was safe and potentially associated with improved CD-related outcome measures in patients on a GFD. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28035551",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}